Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal Neuroblastoma
Neuroblastoma is a rare childhood cancer that often starts in the tummy. Standard radiotherapy uses X-rays to destroy cancer cells, but these rays can sometimes affect nearby healthy organs and cause long-term side effects. Proton beam therapy (PBT) is an advanced type of radiation that stops directly within the tumour, reducing radiation to healthy growing tissues. The SUPERMAN study is part of an NHS England programme looking at how proton beam therapy can best help patients with neuroblastoma in the abdomen. Eligible patients receive proton beam therapy at one of two specialist NHS centres in London or Manchester. Researchers want to learn how to tailor and monitor this treatment to keep it as safe and effective as possible. Taking part does not stop patients from joining other clinical trials, and travel support or accommodation is arranged for families who live far from the treatment centres.
At a glance
What is this study about?
Neuroblastoma is a rare cancer that affects around 100 children in the UK each year, most often in children under five. It usually starts in nerve tissues deep inside the tummy (abdomen), near vital organs like the kidneys, liver, and large blood vessels. Treatment often includes chemotherapy, surgery, and radiotherapy to destroy any remaining cancer cells and help stop the cancer from coming back.
Traditional radiotherapy uses high-energy X-rays. While effective, X-rays pass all the way through the body, meaning healthy organs around the tumour receive small amounts of radiation. In growing children, this can sometimes lead to organ problems or a small risk of secondary cancers later in life. Proton beam therapy is a newer technique that uses charged particles instead of X-rays. These beams can be programmed to stop right inside the tumour, which significantly reduces the radiation reaching healthy surrounding tissues.
The SUPERMAN study is an NHS project exploring how to use proton beam therapy most effectively for abdominal neuroblastoma. Because the NHS has two world-class proton centres in Manchester and London, this study allows doctors to carefully track how patients respond and learn how to plan treatments that give the best chance of a cure while keeping side effects as low as possible.
Key takeaways
- SUPERMAN is an NHS study testing proton beam therapy for neuroblastoma in the tummy.
- Proton therapy aims to target cancer cells while protecting healthy surrounding organs.
- Treatment is delivered at specialist NHS centres in London or Manchester.
- Free accommodation is provided for families who live far from the treatment centres.
- Participation is entirely voluntary and does not prevent joining other cancer studies.
Who may be eligible?
This study is open to patients aged 3 months and older who have been diagnosed with neuroblastoma in the tummy or pelvic area and have been recommended for curative radiotherapy by their medical team. Because this cancer mostly affects very young children, the trial is designed with families and young patients in mind.
Patients must be well enough to safely receive radiotherapy. Pregnant individuals cannot take part because radiation can harm an unborn baby, and female patients of childbearing age must agree to use reliable contraception during treatment.
Parents, guardians, or adult patients must give written consent to receive the treatment and to allow their health information to be stored securely on an NHS registry to help future research.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Diagnosed with neuroblastoma in the abdomen (tummy) or pelvis
- Aged 3 months or older
- Considered fit and ready for curative radiotherapy by your medical team
- Not currently pregnant
- Willing to travel to London or Manchester for daily treatment sessions
What does participation involve?
If you or your child take part, treatment will take place at one of the two NHS proton beam therapy centres in Manchester or London. Before treatment starts, the team will perform planning scans, such as a CT scan, to map the tumour precisely. Treatment is typically given once a day, Monday to Friday, over several weeks. Each session takes only a short time, during which the patient lies still on a treatment couch. For young children who find it difficult to stay still, a short, gentle general anaesthetic is used each day to keep them relaxed and safe. Doctors and nurses will check health and side effects throughout the treatment period. After therapy finishes, the team will arrange regular follow-up visits over several months and years to monitor recovery. Free accommodation is provided near the centre for families travelling from elsewhere in the UK.
Potential risks and benefits
Locations (2)
- University College London Hospitals NHS Foundation TrustVerified postcodeLondon, United Kingdom· Recruiting
- The Christie NHS Foundation TrustVerified postcodeManchester, United Kingdom· Recruiting
Common questions
What makes proton beam therapy different from standard radiotherapy?
Standard radiotherapy uses X-rays that travel through the body, while proton beams stop precisely inside the tumour, sparing more of the healthy tissue behind it.
Where does the treatment take place?
Treatment takes place at one of the two specialist NHS proton centres, located at The Christie in Manchester and University College London Hospitals (UCLH) in London.
Will my child need to be put to sleep for treatments?
Young children who cannot lie completely still for the beam are usually given a short, gentle general anaesthetic by a specialist paediatric team for each session.
Can my child join other cancer studies at the same time?
Yes. Taking part in SUPERMAN does not stop your child from participating in other neuroblastoma clinical trials, including international trials like SIOPEN-HR-NBL2.
Do we have to pay for accommodation if we live far away?
No. The NHS provides accommodation close to the proton centres in Manchester and London for patients and their families during treatment.
How to find out more
Pei Lim, BM, MSc, MD(Res), MRCP, FRCR
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.